Top Markets
Coin of the day
Hansa Biopharma AB Hansa Biopharma AB

Hansa Biopharma AB

HNSBF
Pozycja w akcjach #15161
Hansa Biopharma AB (publ), a biopharmaceutical company, engages in development... Hansa Biopharma AB (publ), a biopharmaceutical company, engages in development and commercialization of treatments for patients with rare immunological conditions in Sweden, North America, and rest of Europe. The company offers Idefirix(imlifidase), which targets and cleaves all classes of immunoglobulin G (IgG) antibodies for the desensitization treatment of sensitized adult kidney transplant patients with a positive crossmatch test. It is also developing HNSA-5487, a next generation IgG-cleaving enzyme to address acute and chronic neuro-autoimmune conditions, including myasthenia gravis. In addition, the company evaluates imlifidase in three therapy areas, including autoimmune, gene therapy, and transplantation. It has a collaboration agreement with Sarepta Therapeutics to assess imlifidase as a pre-treatment in limb-girdle muscular dystrophy (LGMD) and duchenne muscular dystrophy (DMD); AskBio to evaluate imlifidase as a pre-treatment in pompe disease; and research and development collaboration agreement with Genethon to evaluate the safety and efficacy of imlifidase as pre-treatment to gene therapy in Crigler-Najjar syndrome patients with anti-AAV antibodies. Hansa Biopharma AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.
Cena akcji
$3.70
Ostatnia synchronizacja: 2026-08-28
Kapitalizacja rynkowa
$369.01M
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
35.04%
Kraj
SE
Handel Hansa Biopharma AB (HNSBF)

Kategoria

Historia ceny akcji dla Hansa Biopharma AB (HNSBF)
Najwyższa cena zamknięcia: $3.70 dnia 2026-08-01

Najniższa cena zamknięcia: $4.71 dnia 2015-03-01
Historia cen akcji firmy Hansa Biopharma AB od 2015 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) 7.87%
2025 -0.21%
2024 29.03%
2023 -54.16%
2022 -51.64%
2021 -65.44%
2020 200.34%
2019 -69.02%
2018 10.98%
2017 118.54%
2016 302.77%
2015 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$61.61 71.22%
US
$51.09 69.52%
SE
$194.53 42.09%
FR
$62.45 0.05%
IT
$113.45 62.73%
US